-+ 0.00%
-+ 0.00%
-+ 0.00%

PASITHEA THERAPEUTICS PRESENTS UPDATED INTERIM DATA FROM ONGOING PHASE 1 STUDY OF PAS-004 AT THE ASCO ANNUAL MEETING 2025

Reuters·06/02/2025 12:02:00

Please log in to view news